check_circleStudy Completed

Pseudomonas

Anti-Pseudomonas treatment in patients with cystic fibrosis

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

8 - 25 Years
  • -

  • -

Trial summary

Enrollment Goal
45
Trial Dates
March 1988 - February 1992
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Cipro (Ciprofloxacin, BAYQ3939)
Accepts Healthy Volunteer
N/A

Trial design

Anti-Pseudomonas treatment in patients with cystic fibrosis "optimal" 2 week inpatient "intensive treatment" consisting of ceftazidime with amikacin (AK) i.v. plus AK p.i. (by inhalation) subsequent 3-month "maintenance treatment" with ciprofloxacin p.o. prospective randomized study with and without additional use of AK p.i.
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A